Dapirolizumab pegol not checked

UCB Biopharma SRL · CDP7657

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
5 in total · 3 in the EU
Targets
—
None known yet

What this is

How it works
An antibody: a lab-made immune protein built to latch onto one target in the body.-mab: monoclonal antibodies WHO name stem
How it’s given
“Study participants will receive dapirolizumab pegol (DZP) at prespecified time-points.”In the company’s words, NCT06617325 on ClinicalTrials.gov
Tested for
Systemic Lupus Erythematosus (3 trials)
Main trialPhase 3
“The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.”In the company’s words, NCT06617325 on ClinicalTrials.gov
Other names
DZP · CDP7657

Other drugs for Systemic Lupus Erythematosus

All 131 drugs for Systemic Lupus Erythematosus

Coming up3

Changes1

Last 90 days

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 31 May 2028 A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Phase 3Enrolling by invitation 7 Aug 2030 A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Phase 1Not yet recruiting 31 Dec 2028 A Study to Evaluate the Placental Transfer of Dapirolizumab Pegol to the Infant(s) From Pregnant Study Participants With Active Systemic Lupus Erythematosus Who Are Administered Dapirolizumab Pegol
Phase 3Completed 22 May 2024 A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Phase 2Completed 31 May 2018 A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Dapirolizumab pegol

Following is part of Solo: you see every change to Dapirolizumab pegol the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in